• GSK halts US sales of its blood cancer drug Blenrep

    2 days ago - By Natural News

    British pharmaceutical firm GSK announced that it will stop selling its blood cancer drug Blenrep in the United States. The company announced on Nov. 22 that it has begun the process to withdraw the drug's marketing authorization in the country. It clarified, however, that trials for the drug would continue and that some...
    Read more ...